NCT01997333 · Interventional trial
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer
Overall registry status Completed
Phase 2
Conditions Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- St Mary Medical Center · Langhorne, PA · Bucks County
First posted
Registry updated
Added to the directory